-transparent.png){kind=logo}
Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. We tested the effect of pyridoxine (300-mg iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorhea-amenorrhea syndrome will require further study.
Related Publications
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
January 1980,
Neuroendocrinology,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
September 1989,
The Journal of clinical endocrinology and metabolism,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
October 1978,
Metabolism: clinical and experimental,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
October 1977,
The Journal of clinical endocrinology and metabolism,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
January 1986,
The Journal of clinical endocrinology and metabolism,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
February 1984,
Bollettino della Societa italiana di biologia sperimentale,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
October 1982,
Horumon to rinsho. Clinical endocrinology,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
September 1978,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
November 1981,
Neuroendocrinology,
A M Spiegel, and
S W Rosen, and
B D Weintraub, and
S P Marynick
July 1983,
Clinical pharmacology and therapeutics,
